Current status and future prospects for epigenetic psychopharmacology - Test2 - elhamkhani - TriplyDB

Current status and future prospects for epigenetic psychopharmacology

Current status and future prospects for epigenetic psychopharmacology

http://www.wikidata.org/entity/Q26825464

about

Childhood exposure to violence and lifelong health: clinical intervention science and stress-biology research join forces Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics Molecular dynamics simulations indicate an induced-fit mechanism for LSD1/CoREST-H3-histone molecular recognition Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults Whole genome methylation analyses of schizophrenia patients before and after treatment.Effect of valproic acid on mitochondrial epigenetics Methods to analyze big data in pharmacogenomics research.Epigenetic studies of schizophrenia: progress, predicaments, and promises for the future.High quality methylome-wide investigations through next-generation sequencing of DNA from a single archived dry blood spot.Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits.Epigenetic studies in Alzheimer's disease: current findings, caveats, and considerations for future studies.Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders.Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs.Epigenetics and depressive disorders: a review of current progress and future directions.Traumatic stress and human DNA methylation: a critical review.Understanding epigenetic architecture of suicide neurobiology: A critical perspective.Epigenetics at the crossroads between genes, environment and resilience in anxiety disorders.DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder.S-Adenosyl Methionine in the Therapy of Depression and Other Psychiatric Disorders.Epigenetic regulation of melatonin receptors in neuropsychiatric disorders.Repeated treatment with electroconvulsive seizures induces HDAC2 expression and down-regulation of NMDA receptor-related genes through histone deacetylation in the rat frontal cortex.Biological Predictors of Clozapine Response: A Systematic Review

P2860

Q24629111-E1730904-E5C0-4949-B03D-FF74671C18EF Q24629465-A468C299-3E19-4E95-B29A-6B34ABBAF2C4 Q28079065-FAB02F58-51CC-40D5-B849-AC77C2ABF3D3 Q34243848-17600E07-C2F3-4B2C-BF32-FFD5A7F8C12A Q35090701-BBF330F9-12B9-46C7-A8FF-887DBEEB0410 Q35614046-023005CF-F94F-44D2-A88B-1B377BE2819F Q36165223-0F6C06B5-FCEF-42F4-8AE1-D238E555F761 Q36404935-148A0D7B-1235-4878-A1FD-31C98F891884 Q36471524-30CB0FC0-E701-4448-AA2F-171EF104D6EA Q37089523-77EF2BE1-73C6-4C41-9AD2-57D7A7AE2739 Q37529899-8B097128-EF1C-4FE9-BD7B-F3B4E6BCF94D Q37626479-E0253C9F-282D-4270-B939-2277B05338AB Q38019745-F1470826-2AEC-49DA-A43E-5E54E4EB829C Q38068561-BADBAB01-325D-42B0-9C95-BDC66B285F40 Q38365358-E6D7C59A-9E98-48B4-AA63-F3B3CDBC1177 Q38537763-4A0F2634-AE90-4AC3-8CF8-7859D86EA86E Q39005702-A1F6856C-5D14-42FA-A556-2C14ADEE24E8 Q39312328-7EE7743A-D605-4226-81CE-8D2E4BFA7A2F Q47593705-B371FD21-47C8-4C37-9C94-7371A8BC7E7F Q47946109-C8C9D680-9598-48A6-9A98-D631847C313C Q48088836-56FF9283-460E-4444-BE19-56971CDC09C1 Q53292303-8D0CD441-45E7-4FA8-AE71-5979EF365F3A Q57174550-0866BDD0-EDC9-425B-8B81-3AFDA7B78CD7

P2860

Current status and future prospects for epigenetic psychopharmacology

http://www.wikidata.org/entity/Q26825464

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Current status and future prospects for epigenetic psychopharmacology

@ast

Current status and future prospects for epigenetic psychopharmacology

@en

Current status and future prospects for epigenetic psychopharmacology

@nl

type

label

Current status and future prospects for epigenetic psychopharmacology

@ast

Current status and future prospects for epigenetic psychopharmacology

@en

Current status and future prospects for epigenetic psychopharmacology

@nl

prefLabel

Current status and future prospects for epigenetic psychopharmacology

@ast

Current status and future prospects for epigenetic psychopharmacology

@en

Current status and future prospects for epigenetic psychopharmacology

@nl

P1433

Q26825464-99396EF2-DFF2-4FCF-A2C9-7524A2BC1C4A

P1476

Q26825464-6ADDCB45-5D2F-441E-B906-3AD9E0FA7290

P2093

Q26825464-08388F2A-8F25-4D3D-B738-09E2DE2A64AE

Q26825464-18F4CE5B-F776-4F77-9A2D-F6CF7D1473FE

Q26825464-2E322C48-7664-4461-8EC7-4F5D2EBFE1A1

Q26825464-E229D725-3AFC-4E04-8E93-4BF62F45C9DE

P2860

Q26825464-04789E04-4302-4A7B-9A60-67A16AA7E43E

Q26825464-05CC385B-6378-4FDB-96C1-2E40F80B74A8

Q26825464-069224EE-AA4B-47D8-9C16-D9CA86C261F3

Q26825464-0FEECC9B-B771-4043-9070-6A0EC2135364

Q26825464-15748B60-FE10-4F3C-B00D-FBD047AAE5C9

Q26825464-197D4BD2-1736-45E6-A210-5C9505CF2D37

Q26825464-1AA4E08E-FEC7-4312-B433-488CB6EDF23A

Q26825464-1AC05DC9-C9A9-4069-82A7-D0BB47520A39

Q26825464-1FB74C26-F3C5-401D-BAE9-A1D4C16E2734

Q26825464-20B2FB94-D96E-4F85-BE6C-253574D9E753

P304

Q26825464-BEEFD0BA-4CC5-4607-A29D-E9E74A005E07

P31

Q26825464-608E5BD3-2917-4711-A346-F3C0D491188C

P3181

Q26825464-DDA907A4-4431-4C6C-BD9A-2AC180BED736

P356

Q26825464-C17AD9C3-1498-40B5-BCF4-EA264928C6AC

P407

Q26825464-038B1806-3E50-4154-8B68-8E0BE8B12E15

P433

Q26825464-974EF54E-2B39-47BF-912E-66AB302906E8

P478

Q26825464-29041F63-D448-4255-822A-C22AACB4B058

P50

Q26825464-111172BD-B0C5-4B01-ADD4-DD34EB8016CF

Q26825464-138F3BCA-4DEA-411E-B041-979F5041102D

Q26825464-C70E1DD4-DA96-4639-AC58-E0235826C134

Q26825464-D4F187FF-2F09-4F5D-A5AE-66BA85615C59

P577

Q26825464-22C12098-39A7-4DFD-9DD2-B215D0A23420

P5875

Q26825464-8A102BD9-040F-4640-AF7F-4A516FFE9361

P698

Q26825464-C44E7454-5A00-4211-84AA-D96C5A066915

P932

Q26825464-CDB36C2F-C681-4203-ADA0-83E621163B16

P3181

P356

P1433

P1476

Current status and future prospects for epigenetic psychopharmacology

@en

P2093

Christiaan H. Vinkers

http://www.w3.org/2001/XMLSchema#string

Martien J.H. Kas

http://www.w3.org/2001/XMLSchema#string

Noëlle M. de Jong

http://www.w3.org/2001/XMLSchema#string

Roel A. Ophoff

http://www.w3.org/2001/XMLSchema#string

P2860

Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates

The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain

Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia

On the epigenetic regulation of the human reelin promoter

Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood

Histone methylation regulates memory formation.

Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation

Epigenetic mediation of environmental influences in major psychotic disorders

Epigenomic profiling reveals DNA-methylation changes associated with major psychosis

P304

20-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2650599

http://www.w3.org/2001/XMLSchema#string

P356

10.4161/EPI.7.1.18688

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Cathy Fernandes

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51970991

http://www.w3.org/2001/XMLSchema#string

P698

22207355

http://www.w3.org/2001/XMLSchema#string

P932

3329498

http://www.w3.org/2001/XMLSchema#string